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height; only the ﬁrst full step was used to calculate the equilibrium
modulus. HTMS results were compared to single Instron tests to
determine the accuracy of the device. Injury: Cartilage analogs (CTAs:
scaffold-less bovine chondrocytes) were individually compressed to
75% or 50% strain at 50% strain/s and harvested 12, 24, and 120 hrs post-
trauma. Subsequently, the HTMS device was used to compress
constructs to 60% strain at 50%/s, with harvest at 24 and 120hrs.
Outcome assays: DMMB to measure construct and soluble GAG; Griess
to measure nitric oxide (NO); and RT-PCR to ECM and protease gene
expression. Live/Dead imaging and Alcian blue staining (proteoglycans)
were used to visualize cell death and matrix loss after injury.
Results: HTMS: The HTMS device reliably and accurately measured the
compressive mechanical properties of both 15% PA and 4% Ag gels (Fig
1B). Both the mean and standard deviation of HTMS versus Instron
measured Young's moduli were similar. Speciﬁcally, the HTMS-derived
EY of 15%PA was 83.4+/-27.5 kPa and of 4%Ag was 49.4+/-12.2 kPa,
which was not signiﬁcantly different from the Instron EY of 79.8+/-15.5
kPa and 43.3+/-9.5 kPa, respectively. These results illustrate that the
device can determine differences between construct populations as
small as w30kPa (Fig 1A).
Figure 1. - Testing of multiple samples in the HTMS device. (A) Equilibrium modulii of
15% Polyacrylamide and 4% Agarose gels measured using the HTMS device (HTMS:
n¼24/group) shows signiﬁcant differences between the two (p<0.0001, unpaired t-
test) (B) Quantitative comparisons between high throughput (HTMS) and sample-by-
sample (Instron) analysis demonstrate the reliability of the device and similarity of
variances (Instron: n¼3/group).
Injury: The catabolic response to injury was strain-dependent, as evi-
denced by NO release (Fig 2A). Nitrite concentrations peaked at 24 hrs
for both strain levels, and was signiﬁcantly higher for 75% compared to
50% strain. Similarly, NO peaked at 24 hrs following HTMS injury (Fig
2B). Live/Dead imaging showed cell death predominantly in areas
adjacent to ﬁssures in the tissue, while Alcian blue staining showed loss
of PG in these damaged areas (Fig 2C).
Figure 2. (A) Preliminary results evaluating several injurious compression impact
protocols on CTAs. Nitrite release to the media at 12, 24, and 120 hours post injury
show strain-dependent level of induced injury. p<0.0S * vs 50 and 75% strain and $ vs
75% strain (same time point); @ vs other time points. Nitrite is a by-product of nitric
oxide which is a key molecule that mediates inﬂammatory processes, (B) Preliminary
results evaluating injurious compression applied using the HTMS device. Similartrends in nitrite are observed as in single impact tests. p<0.05 * vs control at 24 hrs. (C)
Live/Dead and Alcian Blue staining of impacted CTAs from HTMS tests show cell death
and ﬁssure formation post-impact.
Conclusions: HTMS approaches can serve as valuable tools for inves-
tigating the development of mechanical properties in engineered
cartilage, as well as the mechanisms governing the chondrocyte
response after injury in PTOA. Our device can evaluate and distinguish
between the properties of two hydrogels, reliably and accurately rela-
tive to traditional lower throughput methods. In addition, we can
induce catabolic responses following injury in engineered cartilage,
which parallels studies of osteochondral explants. Future studies will
evaluate mediators that could control the inﬂamasone after injury and
screen small molecule libraries for therapeutics critical to advancing
PTOA therapy.
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A SYSTEMS BIOLOGY APPROACH IDENTIFIES HEPARIN-BINDING EGF-
LIKE GROWTH FACTOR AS A POTENTIAL MEDIATOR IN OA
R.F. Loeser y, D.L. Long y, A.L. Olex z, J.S. Fetrow z. yWake Forest Sch. of
Med., Winston-Salem, NC, USA; zWake Forest Univ., Winston-Salem, NC,
USA
Purpose: In order to discover novel mediators that may play a role in
OA, we used computational modeling of gene expression microarray
data to determine pathways regulated during the development of OA in
mice. From this analysis, we chose heparin-binding EGF-like growth
factor (HB-EGF) for further functional studies.
Methods: 12 week-old male C57/BL6 mice underwent surgical desta-
bilization of the medial meniscus (DMM) to induce OA or sham surgery
as control. Joint tissues were collected for isolation of RNA (n¼9 mice
per surgical group per time point) pre-surgery (time 0) and at 2, 4, 8,
and 16 weeks after surgery. RNA used for microarrays and real-time PCR
was isolated from pooled joint tissue collected from the medial side of
the joint, including cartilage, meniscus, subchondral bone, and joint
capsule with synovium. Genes passing a detection ﬁlter, SLR ﬁlter (0.5
or-0.5 for at least one time point in all 3 pools), and a consistency ﬁlter
were used for computational modeling. The gene expression data was
overlaid on a protein-protein interaction network extracted from the
Kyoto Encyclopedia of Genes and Genomes (KEGG) and then jActive-
Modules (JAM) was used to identify sub-networks that were signiﬁ-
cantly regulated at the various time points in the DMMmice relative to
sham controls. From this analysis, HB-EGF was selected for further
study by immunohistochemistry and by in vitro stimulation studies
using cultured human articular chondrocytes. Effects of recombinant
HB-EGF,  recombinant ﬁbronectin fragments (FN-F), on MMP-13
production were measured by immunoblotting and real time (RT)-PCR
and on Rac activity using an activity assay.
Results: A total of 427 genes passed the consistency and signiﬁcance
ﬁlters. JAM analysis revealed 13 subnetworks from the changes in gene
expression activity during the time course where the majority of up-
regulated genes were up at 2 and 4 weeks after DMM surgery. The
largest subnetwork included several collagens, syndecans, ﬁbronectin,
thrombospondins, TGFb family members, HIF1a and HIF2a, EGF and
PDGF family members, HB-EGF, and MMP-2 (Fig.1). Because it had not
been previously studied in OA and was located at a key point in the
subnetwork, we chose HB-EGF for further analysis. Immunohisto-
chemical staining revealed increased HB-EGF in human OA cartilage
relative to age-matched normal (n¼4 each). Treatment of cultured
human chondrocytes, isolated from normal cartilage, with the catabolic
stimulus FN-f increased HB-EGF expressionwhich peaked at almost 60-
fold (by RT-PCR) at 3 hours. HB-EGF is a known ligand for the EGF
receptor (EGFR) which signals through MAP kinases and the small
GTPase Rac. We found that HB-EGF at 10ng/ml stimulated chondrocyte
Rac activity and phosphorylation of the EGFR, ERK and p38 but not JNK.
High dose (100ng/ml) but not low dose (10ng/ml) HB-EGF stimulated
MMP-13 production in conditioned media, detected by immunoblot-
ting. However, low dose HB-EGF enhanced the MMP-13 production
induced by FN-F by 1.4-fold over FN-f alone and this was completely
inhibited by blocking Rac1 with 100mMNSC23766 or EGFR with 250 nM
AG1478.
Conclusions: An unbiased computational modeling approach discov-
ered that a subnetwork containing HB-EGF was upregulated at early
time points (2 and 4 weeks) in the DMM model of OA. One mechanism
may be the increased formation of FN-fs, known to be present in OA
Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312 S235cartilage, which were found to stimulate HB-EGF expression. Given the
ﬁnding that HB-EGF signals through the chondrocyte EGFR and
promotes MMP-13 production and that it is present in human OA
cartilage, further evaluation of its role in OA is warranted.
Fig 1. Subnetwork produced by JAMs analysis of gene microarray data at the 4 week
time point after DMM surgery.
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ARTICULAR CARTILAGE EXPRESSES THE IL-15 RECEPTOR ALPHA-
CHAIN AND RESPONDS TO IL-15 WITH INCREASED MATRIX
METALLOPROTEINASE-1 AND -3 RELEASE
R. Marpadga y, A. Nair y, M. Huvard z, M. Rollins x, A. Hakimiyan y, L.
Rappaport y, A. Margulis y, S. Chubinskaya y, C.R. Scanzello y. yRush
Univ. Med. Ctr., Chicago, IL, USA; zUniv. of Illinois at Chicago, Chicago,
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Purpose: IL-15, known for its effects on survival and activation of
lymphocytes, plays a role in promoting synovitis in Rheumatoid
Arthritis. IL-15 serum levels have also been associated with develop-
ment and progression of radiographic OA changes, suggesting a possible
role in cartilage erosion. We previously reported that synovial ﬂuid (SF)
IL-15 levels correlate with levels of matrix metalloproteinase (MMP)-1
and MMP-3 in patients with knee OA. These enzymes inﬂuence carti-
lage matrix remodeling and degeneration. In this study, we investigate
IL-15 and IL-15 receptor expression in cartilage, and test whether IL-15
can induce MMP production from cartilage.
Methods: Cartilage samples from organ donors without a history of
arthritis were collected within 24 hours of death. Extent of joint
structural degeneration in each donor was graded using the modiﬁed
Collins score, and ranged from 0 (normal) to 4 (30% full-thickness
erosion+ osteophytes). Tissues were formalin-ﬁxed and parafﬁn-
embedded. Six-micron sections were stained for IL-15 and IL-15Ra
using standard immunoperoxidase technique and polyclonal antibodies
directed against IL-15 (rabbit anti-human IL-15, Abcam) or the IL-15Ra
chain (goat anti-human IL-15 Ra, Santa Cruz Biotechnology). To test
effects of IL-15 on cartilage, 4mm cartilage punch biopsies were
prepared from the tibial surfaces of seven additional organ donors. For
each donor, 2 explants per well were placed in a 24 well plate with
DMEM (+100U/ml Penicillin-Streptomycin). After 24 hours, media was
replaced with 1 ml of fresh media or media + recombinant human IL-15
(100ng/ml, Peprotech, NJ). TNF-a + Oncostatin M (100ng/ml each, R & D
Systems, MN) was used as a positive control. Every two days for up to 10
days, culture supernatants were collected and replaced with fresh
media +/- cytokines. Consecutive two-day supernatants were analyzed
in duplicate for MMP-1, -3 and -9 using a human MMP 3-Plex Immu-
noassay (Meso Scale Discovery).Results: Staining for IL-15 and IL-15Ra was observed in chondrocytes
from all layers (superﬁcial to deep), regardless of Collins grade. For the
explant experiments, results were expressed as the percentage of the
total ng released in 10 days from the untreated control (¼100%) to allow
comparison between donors. The mean release (n¼7 experiments) in
response to IL-15 after 10 days in culturewas not signiﬁcantly increased
compared to control (MMP-1 release: 841%+/- 675 of control, MMP-3:
204% +/- 127, p>0.05), and MMP-9 release (112% +/-66). However, the
effect of IL-15 on MMP-1 and -3 by release by cartilage explants was
highly variable, and when analyzed individually signiﬁcant increases
were observed in ﬁve of the seven experiments (p<0.05 IL-15 compared
to control). MMP-1 release was observed in explants with grade 1- 4
cartilage degeneration, but not normal (grade 0) cartilage. The greatest
magnitude effect was seen in grade 1 (1521% +/- 10 compared to
untreated control) and grade 4 cartilage (1995% +/- 53).
Conclusions: Both IL-15 and IL-15Ra are expressed in cartilage indi-
cating the potential for this tissue to respond to IL-15. In vitro, IL-15
induced MMP-1, and -3, but not -9 release from cartilage explants, but
the release was highly variable and dependent on the presence of
cartilage integrity loss. This is the ﬁrst demonstration that cartilage is
responsive to IL-15, and suggests a novel role for IL-15 in cartilage
catabolism in various forms of arthritis including OA.
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EARLY TRANSIENT INDUCTION OF IL-6 IN A MOUSE JOINT INJURY
MODEL
J.H. Yik, Z. Hu, B.A. Christiansen, D.R. Haudenschild. Univ. of California
Davis, Sacramento, CA, USA
Purpose: Although the etiology of osteoarthritis (OA) is unknown, it is
often associated with joint injuries. For example, w50% of people with
knee injuries, such as an ACL tear, develop post traumatic osteoarthritis
(PTOA) within 10-20 years. Immediately upon injury, the mechanical
damage causes cell death and physical damage to the surrounding
tissues. This is followed by an acute cellular response, which occurs
within a time-scale of minutes to hours. Based on studies of injury in
other tissues, the acute response phase is characterized by the release of
inﬂammatory mediators, including IL-1, IL-6, and TNFa. In chon-
drocytes, exposure to these cytokines can cause the transcriptional
activation of primary response genes (or inﬂammatory genes), and lead
to increased production of matrix degrading enzymes such as MMPs,
collagenases and aggrecanases. This enzymatic degradation of matrix
contributes to OA via a cascade of destructive events. We believe that
awindow for therapeutic intervention exists shortly after injury, during
which attenuating the acute cellular response will decrease the
production of matrix degrading enzymes and thus decrease the likeli-
hood of developing PTOA.
The acute cellular response within hours of knee injury has not been
studied in detail in a mouse model. We have developed a non-invasive
knee injury mouse model, in which the knee joint is injured by a single
mechanical compression. These mice consistently develop osteoar-
thritis in the injured knees within 2-3 months. We examined the
temporal expression of IL-1b, IL-6, and TNFa and their downstream
target MMP13. Our study characterizes the temporal changes in gene
expression shortly after knee trauma and identiﬁes a window of
opportunity for therapeutic intervention.
Methods: The acute cellular response within hours of knee injury has
not been studied in detail in a mouse model. We have developed a non-
invasive knee injury mouse model, in which the knee joint is injured by
a single mechanical compression. These mice consistently develop
osteoarthritis in the injured knees within 2-3months. We examined the
temporal expression of IL-1b, IL-6, and TNFa and their downstream
target MMP13. Our study characterizes the temporal changes in gene
expression shortly after knee trauma and identiﬁes a window of
opportunity for therapeutic intervention.
Results: IL-6 mRNA expression peaked at 8-hours (w8.5-fold over
control) and returned to base line at 3-day post-injury (Fig. 2). IL-6
Receptor expression was detectable in all samples but remained largely
unchanged relative to control. On the other hand, IL-1bmRNA increased
only slightly (w1.6-fold) but signiﬁcantly at 8 and 24 hours post-injury
and also returned to base line after 3 days. Unexpectedly, the expression
of MMP13, which degrades cartilage matrix and is a downstream target
of IL-1b and TNFa, showed no signiﬁcant change. In contrast, TNFa
expression did not change signiﬁcantly throughout the entire 7-days
time course. Taken together, results from our mouse PTOA model
